Gilead Sciences, Inc.: timeline
Every dated event on file, newest first: history, results, dividends, splits, index changes, insider trades, layoffs and recalls, each with its source.
116 events
On the market-cap history; source: Market-cap history on value.today.
Point at a marker under the line to see the event. Green: good news by its nature (a raise, an index entry), orange: bad (a cut, a layoff), grey: neither.
2026
- Nov 16, 20265 insiders sold $29.8 million of shares
Open-market sales between 02 Nov and 16 Nov 2026
Insider buying and large selling · source: SEC Forms 4 and 5
- Oct 29, 2026Results released
Form 8-K filed 29 Oct 2026
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Aug 4, 2026Results released
Form 8-K filed 04 Aug 2026
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- May 7, 2026Results released
Form 8-K filed 07 May 2026
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Apr 30, 2026
- Mar 31, 2026Dividend raised 3.8% to $0.82 a share
Quarter to 31 Mar 2026
Dividend raises and cuts · source: SEC filings (dividends declared per share)
- Mar 25, 2026
- Feb 27, 20263 insiders sold $23.6 million of shares
Open-market sales between 05 Feb and 27 Feb 2026
Insider buying and large selling · source: SEC Forms 4 and 5
- Feb 24, 2026Annual report filed (Form 10-K)
For the year to 31 Dec 2025
Annual reports · source: SEC EDGAR (10-K, 20-F, 40-F)
- Feb 10, 2026Results released
Form 8-K filed 10 Feb 2026
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Jan 21, 2026
2025
- Nov 12, 2025
- Oct 30, 2025Results released
Form 8-K filed 30 Oct 2025
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Aug 7, 2025Results released
Form 8-K filed 07 Aug 2025
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Aug 6, 2025
- Jun 11, 2025
- Apr 24, 2025Results released
Form 8-K filed 24 Apr 2025
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Mar 31, 2025Dividend raised 2.6% to $0.79 a share
Quarter to 31 Mar 2025
Dividend raises and cuts · source: SEC filings (dividends declared per share)
- Mar 27, 2025
- Feb 28, 2025Annual report filed (Form 10-K)
For the year to 31 Dec 2024
Annual reports · source: SEC EDGAR (10-K, 20-F, 40-F)
- Feb 11, 2025Results released
Form 8-K filed 11 Feb 2025
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
2024
- Nov 29, 20244 insiders sold $41.6 million of shares
Open-market sales between 06 Nov and 29 Nov 2024
Insider buying and large selling · source: SEC Forms 4 and 5
- Nov 13, 2024
- Nov 6, 2024Results released
Form 8-K filed 06 Nov 2024
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Sep 19, 2024Recall: Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Fos
105,000 vials
Product recalls · source: Drugs (FDA)
- Aug 8, 2024Results released
Form 8-K filed 08 Aug 2024
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Apr 25, 2024Results released
Form 8-K filed 25 Apr 2024
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Apr 23, 2024
- Mar 31, 2024Dividend raised 2.7% to $0.77 a share
Quarter to 31 Mar 2024
Dividend raises and cuts · source: SEC filings (dividends declared per share)
- Feb 6, 2024Results released
Form 8-K filed 06 Feb 2024
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
2023
- Nov 7, 2023Results released
Form 8-K filed 07 Nov 2023
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Oct 4, 2023
- Oct 4, 2023
- Aug 3, 2023Results released
Form 8-K filed 03 Aug 2023
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Apr 27, 2023Results released
Form 8-K filed 27 Apr 2023
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Mar 31, 2023Dividend raised 2.7% to $0.75 a share
Quarter to 31 Mar 2023
Dividend raises and cuts · source: SEC filings (dividends declared per share)
- Feb 2, 2023Results released
Form 8-K filed 02 Feb 2023
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
2022
- Dec 25, 2022Market cap passed $100 billion
$106.3 billion on 25 December 2022, from $89.4 billion on 7 January 2022.
Company history · source: Market-cap rankings
- Oct 27, 2022Results released
Form 8-K filed 27 Oct 2022
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Aug 2, 2022Results released
Form 8-K filed 02 Aug 2022
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Apr 28, 2022Results released
Form 8-K filed 28 Apr 2022
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Mar 31, 2022Dividend raised 2.8% to $0.73 a share
Quarter to 31 Mar 2022
Dividend raises and cuts · source: SEC filings (dividends declared per share)
- Feb 1, 2022Results released
Form 8-K filed 01 Feb 2022
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
Share price moves are worked out where the site has the listing's daily prices from the exchange itself: India (NSE), Taiwan (TWSE, TPEx), Brazil (B3), Poland (GPW), Russia (MOEX), Hong Kong (HKEX) and Sri Lanka (CSE). US listings have no daily price source on the site yet.